Bacterial multidrug efflux pumps play an important role in the antimicrobial resistance of gram-negative pathogens (15, 17) , particularly Pseudomonas aeruginosa, where five multidrug efflux systems (MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY-OprM, and MexJK-OprM) have been described to date (16, 18, 21) . Of particular significance is the MexABOprM efflux system, which is expressed constitutively, thereby contributing to the well-known intrinsic resistance of this organism to multiple antimicrobials (11, 12, 14, 23) , and is also hyperexpressed in nalB multidrug-resistant mutants as a result of mutations in the mexR gene (8, 19, 20, 24, 26) . The mexR gene is transcribed divergently from the mexAB-oprM genes and encodes a repressor of the MarR family of regulators (19) . MarR is responsible for regulating expression of the marRAB (mar) operon associated with a multiple antibiotic resistance (mar) phenotype in Escherichia coli (2) . MexR has been shown to bind, possibly as a dimer, to two sites in the mexR-mexA intergenic region, overlapping promoters for mexR and mexAB-oprM (6) , consistent with its observed repression of these promoters (19, 24) . To elucidate the effect of mexR mutations on MexR repressor activity and thereby identify functionally important residues in the protein, the influence of mexR mutations in nalB strains on MexR production and dimerization was assessed.
Bacteria (Table 1) were cultivated at 37°C in Luria-Bertani (LB) broth (Difco) supplemented as needed with tetracycline (10 g/ml for E. coli; 100 g/ml for P. aeruginosa), ampicillin (50 g/ml), chloramphenicol (30 g/ml), and mercuric chloride (15 g/ml). Mutated mexR genes were PCR amplified from several P. aeruginosa nalB strains using primers MEXRF1 (5Ј-GCGAGAATTCCGTTCGTTGCATAG-CGTTGTC-3Ј; Eco-RI site underlined) and MEXRB1 (5Ј-GCGAGAATTCCGA AGGCATTCG-CCAGTAAGC-3Ј; EcoRI site underlined). PCR mixtures (100 l) contained 1 g of chromosomal DNA (prepared as described elsewhere [4] ), 2.5 U of Vent DNA polymerase (New England Biolabs, Mississauga, Ontario, Canada), a 0.2 mM concentration of each deoxyribonucleotide triphosphate, 2.5 mM MgSO 4 , a 0.3 M concentration of each primer, 1ϫ ThermoPol buffer (New England Biolabs), and 10% (vol/vol) dimethyl sulfoxide. Mixtures were heated for 2 min at 94°C followed by 30 cycles of 94°C for 30 s, 56°C for 1 min, and 72°C for 1 min, before finishing with 72°C for 10 min. PCR fragments were electrophoresed on and recovered from 1.2% (wt/vol) agarose gels using the Prep-a-Gene DNA purification kit (Bio-Rad Laboratories) as outlined by the manufacturer. Following digestion with EcoRI and cloning into pRK415 (Table 1) , mexR sequences were validated by nucleotide sequencing using primer PMSLA25 (5Ј-GGATTCGTC TGTTGCAGG-3Ј). The cloned mexR genes were then mobilized into P. aeruginosa via triparental mating (25) with transconjugants selected on tetracycline (100 g/ml) and imipenem (0.5 g/ml; for counterselection). Wild-type and mutant mexR genes derived from nalB strains were also PCR amplified (as above) and cloned into the bacterial two-hybrid vectors pDP804 and pMS604 (Table 1) . For cloning into pDP804, primers XhoILA7 (5Ј-GCAG-CTCGAGATGAACT ACCCCGTGAATCC-3Ј; XhoI site underlined) and BglI-ILA11 (5Ј-GCGGAGATCTAATATCCTCAAGCGGTTGC-GCG-3Ј; BglII site underlined) were used, while for cloning into pMS604, primers BstEIILA8 (5Ј-GAGCGGTGACCATG AACTACCCC-GTGAATCC-3Ј; BstEII site underlined) and XhoILA12 (5Ј-GAGGCTCGAGAATATCCTCA-AGCGTT GCGCG-3Ј; XhoI site underlined) were used. Reaction mixtures were formulated and heated as above, with the exception that wild-type mexR was amplified from plasmid pRSP55 (20 ng) . PCR products were purified as above, restricted with XhoI and BglII or BstEII and XhoI, and cloned into XhoI-BglIIdigested pDP804 or BstEII-XhoI-digested pMS604, as appropriate. Following cloning, the mexR sequences were validated by nucleotide sequencing using primer PMSLA25. Plasmid DNAs were prepared using the Qiagen miniprep kit as recommended by the manufacturer.
Cell envelope proteins were prepared as described previously (22) , except that 15 ml of cell culture was harvested in stationary phase. Soluble proteins were recovered by saving the supernatant following centrifugation of cell envelopes. Protocols for sodium dodecyl sulfate-polyacrylamide gel electro-phoresis and Western immunoblotting have been described previously (22) . For gels immunoblotted and developed with an anti-MexR antiserum, 2-mercaptoethanol (2.5% [vol/vol] final concentration) was included in the gel loading buffer (prepared as a 4ϫ stock solution) and the gels were thicker (3 mm) than usual to permit more sample to be loaded. Antibody to MexR was prepared in New Zealand White rabbits (by L. Mutharia, University of Guelph, Guelph, Ontario, Canada) using purified histidine-tagged MexR (6) as antigen, and it was adsorbed against whole-cell lysates of P. aeruginosa K1491 prior to use. The protocol for antimicrobial susceptibility has been described elsewhere (22) . Two-hybrid systems are routinely used to assess proteinprotein interactions, and a recently developed bacterial version of this system has proven useful in this regard (5) . The system is based on LexA, a protein that binds only as a dimer to the sulA operator and in so doing downregulates transcription. Using vectors (pMS604 and pDP804) engineered to encode only the DNA-binding domain of LexA (hereafter called LexAЈ) and a reporter strain with a lacZ gene controlled by a sulA operator (E. coli SU202), one simply clones genes and sequences predicted to encode interacting proteins and domains as fusions to lexAЈ and screens for repression of lacZ (i.e., reduction in ␤-galactosidase activity). Such repression requires dimerization of the LexA DNA-binding domain, which will occur only if the protein sequences fused to LexAЈ are able to interact. Since the system was originally designed to assess interactions between heterologous proteins, the lexAЈ sequence in one plasmid (pMS604) was altered such that its LexAЈ bound to an altered operator sequence and the reporter strain carried a hybrid sulA operator, such that only LexAЈ heterodimers would bind and repress lacZ. The two-hybrid vectors also contain sequences encoding Jun and Fos zipper motifs (known to interact) fused to lexAЈ, such that E. coli SU202 carrying these vectors demonstrates substantial repression of lacZ ( Table 2 ). The unaltered vectors thus provide a positive control for the system, although the Jun and Fos zipper-encoding sequences will be disrupted upon cloning test sequences into the two-hybrid vectors (and, thus, lacZ repression will be dependent upon interaction of protein sequences encoded by the cloned DNA).
In utilizing this system to assess MexR dimerization, then, the mexR gene was cloned into pDP804 and pMS604, and E. coli SU202 isolates carrying these vectors was cultured overnight in antibiotic-supplemented LB broth and diluted 1:99 in fresh LB medium supplemented with appropriate antibiotics and isopropyl-␤-D-thiogalactopyranoside (1 mM). Once cultures had reached an optical density at 600 nm of 0.4 to 0.8, ␤-galactosidase assays were performed as described by Miller (14a). As seen in Table 2 , E. coli SU202 carrying one or the other of the two-hybrid vectors demonstrated substantial ␤-galactosidase activity, consistent with the absence of LexAЈ dimerization. When wild-type mexR genes were cloned into both two-hybrid vectors, E. coli SU202 harboring the resultant plasmids (pLK451 and pLK452) showed a substantial decrease in ␤-galactosidase activity below that seen for the vectors-only positive control, indicating that LexAЈ and, thus, MexR, was dimerizing. Dimerization has been reported for MarR, whose crystal structure is known (3), and the recent MexR crystal structure confirms the dimeric nature of MexR (13) .
Mutations in mexR compromise MexR repressor activity, leading to MexAB-OprM hyperproduction in nalB mutants.
Loss of activity might result, however, from protein instability, loss of dimerization, or defects in DNA binding. Initially, then, several nalB strains were screened for production of MexR. Intriguingly, although nalB strains show increased mexR gene expression owing to the characteristic mexR-negative autoregulation (19), many nalB strains produced little or no detectable MexR protein (Fig. 1) . While this might be expected for mutants carrying frameshift mutations in mexR (see reference 24) , those MexR proteins shown in Fig. 1 all carry single amino acid changes only. Some clustering of these mutations is evident (including residues 59 to 83), although the significance of this is not clear. Several nalB strains did, however, produce substantial levels of MexR, far above what was seen in wild-type strains (Fig. 1, lanes 1, 4, and 17 ) and comparable to levels seen in a nalC mutant (Fig. 1, lane 2) which hyperexpresses mexABoprM and mexR as a result of mutation(s) in an as-yet-unknown gene(s) (24) . Thus, loss of repressor activity in these MexR proteins must be due to changes other than protein instability.
To assess the possible impact of the mexR mutation in each of these mutants on protein dimerization, the corresponding genes were amplified by PCR and cloned into the two-hybrid vectors described above. As seen in Table 2 T130P ). The impact of the nalB mutation on MexR in each strain is indicated in parentheses, with the exception of K1455, which is a nalC strain that hyperproduces MexAB-OprM as a result of an unknown mutation. The gel as presented is a composite assembled from lanes of the same gel. a E. coli SU202 harboring the indicated two-hybrid vectors was assayed for ␤-galactosidase activity as described in the text. b ␤-Galactosidase activities are the means of at least three independent determinations, with the standard deviations indicated. c The strain from which the mexR gene was cloned is identified by a subscript. Any changes in MexR encoded by these genes are also highlighted. (Table 2) . Presumably, these MexR proteins interact only weakly or associate abnormally, such that LexAЈ dimers are not positioned in such a way as to bind the sulA operator. Thus, while the aforementioned mutations compromise normal dimer activity by MexR, it is not at all clear that these changes identify residues directly involved in dimerization. The A110T change, for example, is far from sites of interaction between MexR monomers in the crystal structure (13) , where any impact on dimerization or dimer structure would have to occur via conformational changes that interfere with dimerization (or formation of normal dimers).
Only the L95F (pLK455) and R21W (pLK457) changes had no apparent impact on MexR dimerization, with E. coli SU202 isolates expressing these MexR derivatives demonstrating ␤-galactosidase activities that were indistinguishable from that of the same strain expressing the wild-type proteins (Table 2) . It is likely, therefore, that these mutations ultimately compromised DNA binding, though not necessarily because they define DNA-binding domain(s) of the protein. Indeed, while the L95F change occurs in a region of MexR implicated in DNA binding (13) , residue 21 is far from the probable DNA-binding region of the protein. Still, it does occur in a region of MexR where the individual monomers interact with one another. The R21W change may, therefore, alter the positioning of the monomers with respect to one another, altering the proper spacing of the DNA-binding region of each monomer and compromising the ability of MexR dimer to bind to adjacent DNA-binding sites in the mexAB-oprM promoter (6) .
Nonfunctional mutant MexR proteins that dimerize but are unable to bind DNA should be dominant over wild-type MexR and compromise, to some extent at least, wild-type MexR repressor activity when coexpressed in P. aeruginosa (as a result of forming heterodimers). Indeed, negative dominance of marR mutations was previously used to define residues implicated in the DNA binding of this repressor protein (1) . Thus, the cloned mexR genes from nalB strains K1649 (pLK501; expresses MexR L95F ) and K1652 (pLK503; expresses MexR R21W ) were introduced into wild-type P. aeruginosa strain K767, and the impact on mexAB-oprM expression was assessed indirectly by measuring the impact on susceptibility to agents known to be substrates of this efflux system. Initial attempts at measuring the impact on expression directly, using Western immunoblotting with a MexB-specific antiserum, were unsuccessful, likely owing to a lack of sensitivity of the method. As seen in Table 3 , P. aeruginosa K767 isolates carrying pLK501 or pLK503 showed increased resistance to representative antimicrobials relative to that of the vector control or strain K767 expressing wild-type MexR from a plasmid. In contrast, K767 carrying plasmid pLK505 (MexR L57R ) or pLK507 (MexR L13M ) did not show any change in drug susceptibility relative to the vector control. These data are consistent with the former but not the latter MexR derivatives negatively impacting the wild-type repressor activity of the chromosomally encoded MexR protein in strain K767, by the formation of heterodimers unable to bind to the mexAB-oprM promoter region. These data can be interpreted as suggesting a dimerization defect for the MexR L13M and MexR L57R derivatives. Had these variants retained dimerization ability but interfered with LexAЈ binding to sulA (see above), thereby compromising LexAЈ-mediated repression of lacZ in the two-hybrid assay, one would have expected them to be also dominant over wildtype MexR and to enhance multidrug resistance. That they were not suggests that these changes compromised MexR dimerization. Recently, a plasmid-encoded MexR T69I variant (from nalB strain K1651) has been examined in the two-hybrid system and has also been shown to be competent for dimer formation (data not shown), although its dominance over wildtype MexR has yet to be assessed. Like residue L95, residue T69 occurs in a region of MexR implicated in DNA binding (D. Lim, personal communication).
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